Day 1, Session V, VI and Lifetime Accelerator Award

 

SESSION V: Late-Stage and Approved Devices--What is New? moderated by, Daniel Friedman, MD, Assistant Professor of Neurology, New York University

This 6 presentations session includes:

  • Medtronic, Inc. | DBS Therapy for Epilepsy
    Jon Giftakis, PhD, Senior Principal Scientist, Medtronic Neuromodulation
    Starts at 0:47
     
  • NeuroSigma, Inc. | eTNS
    Christopher DeGiorgio, MD, Professor of Neurology, UCLA
    Starts at 10:40
     
  • UCLA | Ultrasound for Seizure Modulation
    John Stern, MD, Director, Epilepsy Clinical Program, UCLA Department of Neurology, Co-Director, UCLA Seizure Disorder Center
    Starts at 23:15
     
  • Visualase, Inc. | Laser Ablation in Neurosurgery
    Ashok Gowda, PhD, Founder and Chief Operating Officer
    Starts at 32:18
     
  • Swedish Neuroscience Institute | MR-guided Focused Ultrasound for Treatment of Mesial TLE
    John Snell, PhD, Technical Director-Brain Program, Focused Ultrasound Foundation
    Starts at 46:10
     
  • Boston Children's Hospital | TMS
    Alexander Rotenberg, PhD, MD, Director, Neuromodulation Program, Associate Professor of Neurology, Boston Children's Hospital, Harvard Medical School
    No powerpoint available during broadcast. Speaker made the above PDF available for offline viewing.
    Starts at 57:09

SESSION VI: Nonprofit Organization, Government and Crowdfunding--Grants, Awards and Funding to Advance Research to the Next Critical Stage, moderated by Roger J. Porter, MD, Chief Scientific Officer, Epilepsy Foundation.
Starts at 1:11:12

This 6 presentations session and panel includes:

  • Jan Buelow, PhD, Vice President Programs and Research, Epilepsy Foundation
     
  • Rajesh Ranganathan, PhD, Director, Office of Translational Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health | Blueprint Program
     
  • H. Steve White, PhD, Research Director, Citizen's United for Research in Epilepsy (CURE), Professor and Director, Anticonvulsant Drug Development Program, University of Utah
     
  • Bre DiGiammarino, Cause Director, Indiegogo | Crowdfunding -- n. & v. The pooling of small contributions of funds from a group of people for the purpose of making something larger happen

Lifetime Accelerator Award: Honoring H. Steve White, PhD
Starts at 2:01:30

<< Previous Video:
Day 1, Early-Stage Diagnostic Devices and Product Pipeline: New Concepts and Initial Findings

>> Next Video:
Day 2, New Directions and Opportunities in Epilepsy Research

I<